News | March 04, 2021
COVAXIN demonstrates interim clinical efficacy of 81%
Bharat Biotech expects to share further details of the trial results as additional data become available.
Bharat Biotech expects to share further details of the trial results as additional data become available.
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .
Fluphenazine Hydrochloride Tablets, USP are available in 1 mg, 2.5 mg, 5 mg, and 10 mg tablets in 100 bottle count sizes.
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The company has posted net profit of Rs.19.8 crores for the period ended December 31, 2020 as against net loss of Rs. 569.7 crores for the period ended December 31, 2019.
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Rivaroxaban is used to treat venous thromboembolism
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Subscribe To Our Newsletter & Stay Updated
